HIV-infected donors present novel source of organs for HIV-infected transplant candidates

May 23, 2011, Wiley

A new study published in the American Journal of Transplantation reveals that HIV-infected deceased donors represent a potentially novel source of organs for HIV-infected transplant candidates that could decrease waitlist deaths and even shorten the national waitlist.

For patients with HIV, there is an increased chance of dying while awaiting transplantation, as the HIV itself causes the risk of dying on the waiting list to be higher. The option of deceased donors who were also infected with HIV could shorten this wait time. However, this is now illegal due to a 1988 Congressional bill.

Led by Dorry Segev, MD, PhD, of Johns Hopkins Medical Institutions, researchers utilized Nationwide Inpatient Sample (NIS) and HIV Research Network (HIVRN) data to assess HIV-infected deaths compatible with donation.

An average of 534 potential donors per year were estimated among inpatient deaths of HIV-infected patients captured in NIS. An average of 494 potential donors per year with well-controlled HIV and causes of death compatible with organ donation were estimated among HIV-infected patients in care.

The results show that organs from approximately 500 HIV-infected, but otherwise healthy deceased donors per year are discarded due to a federal ban on the transplantation of HIV-infected organs.

"HIV/AIDS is no longer an immediate death sentence and can be managed as a , making the ban on transplantation of HIV-infected organs no longer prudent," Segev notes. "If Congress reversed its ban on allowing people with HIV to be after their death, between 500 and 1000 HIV-infected patients with kidney or each year could get transplants faster. This would reduce their risk of death on the waiting list, improve their survival, and even make the list shorter for everyone else who is also waiting for an organ."

Related Stories

Recommended for you

HIV exports viral protein in cellular packages

February 15, 2018
HIV may be able to affect cells it can't directly infect by packaging a key protein within the host's cellular mail and sending it out into the body, according to a new study out of a University of North Carolina Lineberger ...

Can gene therapy be harnessed to fight the AIDS virus?

February 13, 2018
For more than a decade, the strongest AIDS drugs could not fully control Matt Chappell's HIV infection. Now his body controls it by itself, and researchers are trying to perfect the gene editing that made this possible.

Big data methods applied to the fitness landscape of the HIV envelope protein

February 7, 2018
Despite significant advances in medicine, there is still no effective vaccine for the human immunodeficiency virus (HIV), although recent hope has emerged through the discovery of antibodies capable of neutralizing diverse ...

Scientists report big improvements in HIV vaccine production

February 5, 2018
Research on HIV over the past decade has led to many promising ideas for vaccines to prevent infection by the AIDS virus, but very few candidate vaccines have been tested in clinical trials. One reason for this is the technical ...

Microbiome research refines HIV risk for women

January 25, 2018
Drawing from data collected for years by AIDS researchers in six African nations, scientists have pinpointed seven bacterial species whose presence in high concentrations may significantly increase the risk of HIV infection ...

Researchers find latent HIV reservoirs inherently resistant to elimination by CD8+ T-cells

January 22, 2018
The latest "kick-and-kill" research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study by researchers at the George Washington University (GW) found that latent HIV reservoirs show ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.